Mutations of mtDNA in some Vascular and Metabolic Diseases

Area of Science:

• Mitochondrial biology
• Genetics
• Cardiovascular medicine
• Metabolic disorders

Background:

• Chronic diseases, including cardiovascular diseases (coronary heart disease, arterial hypertension, cardiomyopathies) and type 2 diabetes mellitus, are significant causes of mortality.
• Mitochondrial dysfunction is implicated as a potential underlying cause for these chronic conditions.
• Complications such as myocardial infarction and ischemic stroke are common in the progression of these diseases.

Purpose of the Study:

• To review and analyze existing literature on the association between mitochondrial DNA (mtDNA) mutations and chronic diseases of vascular and metabolic origin.
• To explore the potential role of mtDNA mutations in the pathogenesis of these prevalent health conditions.

Main Methods:

• Systematic literature review and analysis of scientific publications.
• Examination of studies investigating genetic variations in mitochondrial DNA.
• Correlation analysis between mtDNA mutations and specific chronic diseases.

Main Results:

• A significant association exists between mutations in the mitochondrial genome and coronary heart disease.
• Mitochondrial DNA mutations are linked to type 2 diabetes mellitus.
• Hypertension and various cardiomyopathies also show associations with mitochondrial genome mutations.

Conclusions:

• Identified mtDNA mutations can serve as biomarkers for assessing predisposition to chronic vascular and metabolic diseases.
• These mutations are valuable for developing molecular-cell models to test drug efficacy for these pathologies.
• mtDNA mutations, particularly those associated with disease absence, represent potential targets for future gene therapy interventions.